Insurance coverage for genomic tests
Copyright policy )NIH| Cancer Center Support Grant ,
NIH| Risk-Benefit Trade-Offs for Whole Genome Sequencing ,
NIH| Genomic sequencing to aid diagnosis in pediatric and prenatal practice: Examining clinical utility, ethical implications, payer coverage, and data integration in a diverse population.
Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A; Quinn, Bruce; Tunis, Sean; Neumann, Peter J; Chambers, James D; +3 Authors
Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A; Quinn, Bruce; Tunis, Sean; Neumann, Peter J; Chambers, James D; Garrison, Louis P; Douglas, Michael P; Weldon, Christine B;
Insurance coverage for genomic tests
On 16 March, the Centers for Medicare and Medicaid Services (CMS) announced that Medicare will cover Food and Drug Administration (FDA)–approved or cleared genomic tests that encompass broad gene panels for advanced cancer patients ([ 1 ][1]). The final policy does not include the initial draft's
United States
- University of Mary United States
- University of California United States
- University of Washington United States
- University of California, San Francisco United States
- UCSF Helen Diller Family Comprehensive Cancer Center United States
General Science & Technology, Medicaid, Humans, Genetic Testing, Genomics, Medicare, Insurance Coverage, United States
General Science & Technology, Medicaid, Humans, Genetic Testing, Genomics, Medicare, Insurance Coverage, United States
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).19 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
selected citations
Citations provided by BIP!
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 19
Top 10%
Top 10%
Top 10%
Green
bronze
Beta
Fields of Science
Funded by
Related to Research communities
Cancer Research